-+ 0.00%
-+ 0.00%
-+ 0.00%

Moleculin Biotech CEO Walter Klemp receives 577 shares as restricted stock units vest

PUBT·11/18/2026 22:16:01
Listen to the news
Moleculin Biotech CEO Walter Klemp receives 577 shares as restricted stock units vest
  • Moleculin Biotech CEO and President Walter V. Klemp acquired 577 common shares through restricted stock unit conversion on Nov. 16, 2026.
  • Following the transactions, Klemp directly held 36,545 common shares and 126,838 restricted stock units.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-037580), on November 18, 2026, and is solely responsible for the information contained therein.